Clinical risk index in urolithiasis.

Area of Science:

• Nephrology
• Urology
• Biochemistry

Background:

• Existing urinary stone risk indices are often laboratory-based and not clinically practical.
• Many current indices fail to account for all potential stone formation influences.
• A comprehensive, clinically applicable risk assessment tool is needed for predicting stone recurrence.

Purpose of the Study:

• To develop and validate a novel clinical risk index for predicting future urinary tract stone formation.
• To assess the correlation between the developed risk index and clinical severity of stone disease.
• To evaluate the impact of lifestyle modifications and medical interventions on the risk index score over time.

Main Methods:

• A risk index was developed using 43 variables, including patient demographics, medical history, and biochemical parameters.
• The index was calculated for 500 stone patients and correlated with clinical severity (nil/low/moderate/severe).
• In a subset of 127 patients, the index was reassessed after one year to observe changes.

Main Results:

• The developed clinical risk index showed a significant positive correlation (r = +0.67, P < 0.001) with the clinical severity of urinary stone disease.
• In 127 patients followed for one year, the mean risk index score decreased significantly from 43.08 to 36.56 (P < 0.01).
• This reduction in risk index was associated with changes in diet, lifestyle, and medication.

Conclusions:

• The developed clinical risk index is a feasible and effective tool for predicting future urinary stone formation.
• The risk of stone formation can be significantly reduced through targeted interventions such as dietary adjustments, lifestyle modifications, and appropriate chemotherapeutic drugs.
• This index provides a valuable framework for personalized risk management in patients with urinary tract stones.